secwatch.observer — SEC 8-K summary
======================================

Issuer:     Eledon Pharmaceuticals, Inc. (ELDN)
CIK:        0001404281
Form:       8-K
Filed at:   2022-06-23T23:59:59+00:00
Accession:  0000950170-22-011978
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Eledon Pharmaceuticals annual meeting elects directors and ratifies auditor
---------------------------------------------------------------------------

- Stockholders elected Keith A. Katkin (7,330,714 for, 765,231 withhold) and John S. McBride (7,287,222 for, 808,723 withhold) as Class II directors for term ending 2025.
- Ratified KMJ Korbin & Company LLP as independent auditor for FY2022 with 10,173,336 for, 10,380 against, 3,433 abstain.
- All proposals passed at the June 21, 2022 annual meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1404281/000095017022011978/0000950170-22-011978-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1404281/000095017022011978/eldn-20220622.htm
  HTML page:      https://secwatch.observer/filing/0000950170-22-011978

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer